Infliximab in the management of severe pemphigus vulgaris.
Pardo
J
J
Mercader
P
P
Mahiques
L
L
Sanchez-Carazo
J L
JL
Oliver
V
V
Fortea
J M
JM
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000627:therapeutic use*; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D010392:Pemphigus / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab